A method to diagnose opioid dependence resulting from heroin versus prescription opioids using the Composite International Diagnostic Interview
- PMID: 20079463
- PMCID: PMC3579622
- DOI: 10.1016/j.cct.2010.01.002
A method to diagnose opioid dependence resulting from heroin versus prescription opioids using the Composite International Diagnostic Interview
Abstract
Treatment research with opioid-dependent populations has not traditionally distinguished between those dependent on prescription opioids versus dependent upon heroin. Evidence suggests there is a substantial subpopulation of individuals with opioid dependence resulting largely or exclusively from prescription opioid use. Because this subpopulation may respond to treatment differently from heroin users, a method for discriminating DSM-IV opioid dependence due to prescription opioid use would provide more precision when examining this population. This paper describes an innovative method using a currently available diagnostic instrument, to diagnose DSM-IV opioid dependence and distinguish between dependence resulting from prescription opioids versus dependence upon heroin.
Copyright 2010 Elsevier Inc. All rights reserved.
References
-
- Substance Abuse and Mental Health Services Administration, O.A.S. The NSDUH Report: Trends in Nonmedical Use of Prescription Pain Relievers: 2002–2007. Rockville, MD: 2009.
-
- Substance Abuse and Mental Health Services Administration, O.A.S. Treatment Episode Data Set (TEDS): 1997–2007. National Admissions to Substance Abuse Treatment Services; Rockville, MD: 2009.
-
- Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 2006;81(2):103–7. - PubMed
-
- Amato L, et al. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev. 2008;4:CD004147. - PubMed
-
- O’Connor PG, et al. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. Am J Med. 1998;105(2):100–5. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- DA013732/DA/NIDA NIH HHS/United States
- K23 DA022297/DA/NIDA NIH HHS/United States
- L30 DA021933/DA/NIDA NIH HHS/United States
- U10 DA15831/DA/NIDA NIH HHS/United States
- K24 DA022288/DA/NIDA NIH HHS/United States
- U10 DA013732/DA/NIDA NIH HHS/United States
- U10 DA13035/DA/NIDA NIH HHS/United States
- U10 DA013045/DA/NIDA NIH HHS/United States
- UG1 DA013732/DA/NIDA NIH HHS/United States
- U10 DA015831/DA/NIDA NIH HHS/United States
- U10 DA013035/DA/NIDA NIH HHS/United States
- UG1 DA015831/DA/NIDA NIH HHS/United States
- UG1 DA013035/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical